Skyrizi 00074-1070

Generic: Risankizumab-Rzaa

Product NDC

00074-1070

Manufacturer: Abbvie Inc.
Dosage Form: Kit
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 16, 2022
Listing Expires: December 31, 2027
Application: BLA761105

Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Drug Class

Interleukin-23 Antagonist [EPC]

Packaging Options(2)

00074-1070-01

1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)

View →

00074-1070-02

1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)

View →